Using natural language processing to identify symptoms in systemic mastocytosis. [PDF]
Xie F +13 more
europepmc +1 more source
The evaluation, management, and future of indolent systemic mastocytosis. [PDF]
Syal A, Toh J, McInerney A, Tremblay D.
europepmc +1 more source
Development of a High-Sensitivity Multiplex mRNA-Based KIT D816V Droplet Digital PCR Assay and Correlation with Tumor Load in Systemic Mastocytosis. [PDF]
Alheraky A +9 more
europepmc +1 more source
Systemic Mastocytosis, KIT and the Effects of KIT Tyrosine Kinase Inhibitors on Mast Cell and Basophil Activation. [PDF]
Valent P +15 more
europepmc +1 more source
CAR T-cells targeting CD117 effectively eliminate mast cells in preclinical models of advanced systemic mastocytosis. [PDF]
Kaiser A +15 more
europepmc +1 more source
Denosumab as a Potential Disease-Modifying Treatment in Indolent Systemic Mastocytosis-Related Osteoporosis. [PDF]
Abbas M, Luthra P.
europepmc +1 more source
Avapritinib reduces symptoms and mast cell burden in systemic mastocytosis. [PDF]
Nöldeke P +4 more
europepmc +1 more source
Aggressive Systemic Mastocytosis Presenting as Diffuse Osteoblastic Bone Disease: A Diagnostic Pitfall Mimicking Metastatic Cancer. [PDF]
Melício A +4 more
europepmc +1 more source
KIT-Negative Systemic Mastocytosis Associated With Acute Myeloid Leukemia. [PDF]
Ali K +6 more
europepmc +1 more source

